相关实验视频
Updated: Sep 13, 2025

07:50
Location, Dissection, and Analysis of the Murine Stellate Ganglion
Published on: December 22, 2020
10.8K
心脏自主神经系统的神经调节用于心律失常治疗
Benjamin Wong1,2, Yuki Kuwabara1, Siamak Salavatian1,2,3
1Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Biomedicines
|July 29, 2025
概括
神经调节技术通过准自主神经系统,为治疗和预防心律失常提供了新的方法. 这些方法,包括神经刺激和切除,在治疗心律障碍方面显得有前途.
科学领域:
- 心脏病学 心脏病学
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
背景情况:
- 心律不整是死亡的主要原因,自主神经系统显著影响其发展.
- 目前对心律失常的治疗有局限性,需要新的治疗策略.
研究的目的:
- 审查当前和新兴的神经调节技术,以治疗和预防心房和心室心律不整.
- 探索心脏自主神经系统在心律失常过程中的作用以及神经调节如何准它.
主要方法:
- 对各种神经调节干预措施的临床前和临床研究的审查.
- 基于目标解剖区域的技术分类 (例如,星状,脊柱区域,副交感系统).
- 包括手术,药物和生物电子方法.
主要成果:
- 详细讨论各种神经调节方法,包括星状质阻断/切除,脊髓刺激,迷走神经刺激和脏皮.
- 展示来自研究的证据,支持这些技术在心律失常管理中的有效性.
- 识别新兴有前途的方法,如针和穿皮磁刺激.
结论:
- 针对心脏自主神经系统的神经调节为心律失常的治疗和预防提供了一个有希望的前沿.
- 广泛的技术,从侵入性到非侵入性,正在研究它们的治疗潜力.
- 进一步的研究和临床验证对于优化这些干预措施以广泛使用至关重要.
相关概念视频
Mechanism of Cardiac Arrhythmias
1.1K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.1K
Dysrhythmias VI: Management of Dysrhythmias
107
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
107
Disturbances in Heart Rhythm
1.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
859
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
859
Regulation of Heart Rates
2.2K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
2.2K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K

